EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antibody Profiling: Kinetics with Native Biomarkers for Diagnostic Assay and Drug Developments

Ute Jucknischke, Sebastian Friebe, Markus Rehle, Laura Quast, Sven H Schmidt

Biosensors · 2023

DOI: 10.3390/bios13121030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors, 2023. Verfasst von Ute Jucknischke und 4 weiteren Autor:innen. Beteiligte Einrichtung: Diagnostic Solutions, Reagent Research and Design, Department Antibody and Protein Technologies, (DSRRA) at Roche Diagnostics GmbH, Nonnenwald 2, 823…. Hauptthemen laut MEDLINE: Antigens, Surface Plasmon Resonance. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite remarkable progress in applied Surface Plasmon Resonance (SPR)-based methods, concise monitoring of kinetic properties for native biomarkers from patient samples is still lacking. Not only are low concentrations of native targets in patient samples, often in the pM range, a limiting and challenging factor, but body fluids as complex matrices furthermore complicate measurements. The here-described method enables the determination of kinetic constants and resulting affinities for native antigens from patients’ cerebrospinal fluid (CSF) and sera binding to antibodies. Using a significantly extended target-enrichment step, we modified a common sandwich-assay protocol, based on a primary and secondary antibody. We successfully analyze antibody kinetics of native targets from a variety of origins, with consistent results, independent of their source. Moreover, native neurofilament light chain (NFL) was investigated as an exemplary biomarker. Obtained data reveal antibodies recognizing recombinant NFL with high affinities, while showing no, or only significantly weakened binding to native NFL. The indicated differences for recombinant vs. native material demonstrate another beneficial application. Our assay is highly suitable for gaining valuable insights into characteristics of native biomarkers, thus impacting on the binder development of diagnostic reagents or pharmaceutical drugs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AntigensSurface Plasmon ResonanceHumansAntibodiesBiomarkers

Stichwörter der Autor:innen

BiacoreGDF15NFLSPRinteraction kineticsnative biomarkerneurofilament light chainsurface plasmon resonance

Substanzen

AntigensAntibodiesBiomarkers

Autor:innen und Institutionen

  • Diagnostic Solutions, Reagent Research and Design, Department Antibody and Protein Technologies, (DSRRA) at Roche Diagnostics GmbH, Nonnenwald 2, 82377 Penzberg, Germany.

Zitieren

APA

Jucknischke, U., Friebe, S., Rehle, M., Quast, L., & Schmidt, S. H. (2023). Antibody Profiling: Kinetics with Native Biomarkers for Diagnostic Assay and Drug Developments. Biosensors. https://doi.org/10.3390/bios13121030

Vancouver

Jucknischke U, Friebe S, Rehle M, Quast L, Schmidt SH. Antibody Profiling: Kinetics with Native Biomarkers for Diagnostic Assay and Drug Developments. Biosensors. 2023. doi:10.3390/bios13121030

BibTeX
@article{Jucknischke2023,
  author = {Jucknischke, Ute and Friebe, Sebastian and Rehle, Markus and Quast, Laura and Schmidt, Sven H},
  title = {Antibody Profiling: Kinetics with Native Biomarkers for Diagnostic Assay and Drug Developments},
  journal = {Biosensors},
  year = {2023},
  doi = {10.3390/bios13121030}
}
Kostenlos starten →